Published Articles
A selection of my published writing across veterinary medicine, biomedical science and agriculture.

Sweet Cherry Compounds Show Promise in Slowing Aggressive Breast Cancer Spread, Texas A&M Study Discovers
Researchers at Texas A&M investigated extracts from dark sweet cherries rich in anthocyanins—natural compounds found in the fruit—for their activity against triple-negative breast cancer (TNBC), a particularly hard-to-treat subtype. In lab models, cherry anthocyanins showed promise both in slowing tumor growth and enhancing the effectiveness of chemotherapy, while also influencing pathways linked to metastasis and drug resistance, suggesting these dietary phytochemicals may offer a complementary approach to conventional treatments.
-

Industry Partnership Drives Texas A&M Study on Tylosin Use and Liver Abscess ControlStudy finds shorter tylosin feeding periods reduce liver abscess risk, though continuous use remains most effective. As consumer demand for beef continues to reach historic highs, feedlot operators are paying close attention to anything that affects cattle health, performance, and carcass value — including liver abscesses, a long-standing and costly challenge in feedlot cattle.

Texas A&M Researcher Receives $2.17 Million Federal Grant To Study Early Brain Changes Linked To Alzheimer’s Disease
Dr. Jianrong Li, a professor and researcher in the Texas A&M University College of Veterinary Medicine & Biomedical Sciences (VMBS), has received a $2.17 million grant from the National Institute on Aging, part of the National Institutes of Health, to examine how support cells in the brain help protect nerve cells and what happens when that protection begins to break down.

Texas A&M Study Reveals How Antibiotic Use During Leukemia Treatment Reshapes the Gut Microbiome
Texas A&M researchers found that antibiotic use during acute myeloid leukemia treatment significantly reshapes the gut microbiome and influences antibiotic resistance patterns. The study underscores the need for more targeted antibiotic strategies during intensive chemotherapy.